Acute and chronic megacolon

Current Treatment Options in Gastroenterology

Volumn 10, Issue 3, 2007, Pages 237-247

  Hanauer, Stephen B ^b   Wald, Arnold ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; ANTIBIOTIC AGENT; ATROPINE PLUS DIPHENOXYLATE; CORTICOSTEROID; CORTICOTROPIN; CYCLOSPORIN A; HYDROCORTISONE; INFLIXIMAB; LOPERAMIDE; MACROGOL; METHYLPREDNISOLONE; NARCOTIC AGENT; NEOSTIGMINE; OPIATE; PLACEBO; PREDNISOLONE SODIUM PHOSPHATE; PREDNISONE;

ABDOMINAL DISTENSION; ABDOMINAL RADIOGRAPHY; BARIUM ENEMA; CECOSTOMY; CHAGAS DISEASE; CLINICAL TRIAL; COLON BIOPSY; COLON DILATATION; COLON PERFORATION; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CROHN DISEASE; CYTOMEGALOVIRUS INFECTION; DECOMPRESSION SURGERY; DIET THERAPY; DISEASE PREDISPOSITION; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; ELECTROLYTE DISTURBANCE; FECES ANALYSIS; FLUID THERAPY; HIRSCHSPRUNG DISEASE; HUMAN; ILEORECTAL ANASTOMOSIS; ILEOSTOMY; INFECTION; INTESTINE ENDOSCOPY; MULTIPLE ORGAN FAILURE; MUSCLE RESECTION; NEPHROTOXICITY; OGILVIE SYNDROME; PERITONITIS; PHYSICAL EXAMINATION; REVIEW; SEIZURE; SEPTIC SHOCK; TOXIC MEGACOLON; ULCERATIVE COLITIS;

EID: 34250672796     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-007-0017-z     Document Type: Review

References (50)

1. Swan NC, Geoghegan JG, O'Donoghue DP, et al.: Fulminant colitis in inflammatory bowel disease: detailed pathologic and clinical analysis. Dis Colon Rectum 1998, 41:1511-1515.
2. Caprilli R, Viscido A, Latella G: Current management of severe ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2007, 4:92-101.
3. Meyers S, Janowitz HD: The place of steroids in the therapy of toxic megacolon. Gastroenterology 1978, 75:729-731.
4. Cottone M, Pietrosi G, Martorana G, et al.: Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001, 96:773-775.
5. Greenstein AJ, Sachar DB, Gibas A, et al.: Outcome of toxic dilatation in ulcerative and Crohn's colitis. J Clin Gastroenterol 1985, 7:137-143.
6. Jakobovits SL, Travis SP: Management of acute severe colitis. Br Med Bull 2005, 75-76:131-144.
7. Hommes DW, Sterringa G, van Deventer SJ, et al.: The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 2004, 10:245-250.
8. Maconi G, Colombo E, Zerbi P, et al.: Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis 2005, 37:418-423.
9. Hanauer SB: Inflammatory bowel disease. N Engl J Med 1996, 334:841-848.
10. Leonard-Jones JE, Ritchie JK, Hilder W, Spicer CC: Assessment of severity in colitis: a preliminary study. Gut 1975, 16:579-584.
11. Gan SI, Beck PL: A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol 2003, 98:2363-2371.
12. Allez M, Lemann M, Bonnet J, et al.: Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy. Am J Gastroenterol 2002, 97:947-953.
13. Almer S, Bodemar G, Franzen L, et al.: Plain X-ray films and air enema films reflect severe mucosal inflammation in acute ulcerative colitis. Digestion 1995, 56:528-533.
14. Caprilli R, Vernia P, Latella G, Torsoli A: Early recognition of toxic megacolon. J Clin Gastroenterol 1987, 9:160-164.
15. Hyde GM, Jewell DP: Review article: the management of severe ulcerative colitis. Aliment Pharmacol Ther 1997, 11:419-424.
16. Travis SP, Farrant JM, Ricketts C, et al.: Predicting outcome in severe ulcerative colitis. Gut 1996, 38:905-910.
17. Carbonnel F, Lavergne A, Lemann M, et al.: Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 1994, 39:1550-1557.
18. Buckell NA, Williams GT, Bartram CI, Lennard-Jones JE: Depth of ulceration in acute colitis: correlation with outcome and clinical and radiologic features. Gastroenterology 1980, 79:19-25.
19. Carbonnel F, Gargouri D, Lemann M, et al.: Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther 2000, 14:273-279.
20. Kornbluth A, Sachar DB: Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004, 99:1371-1385.
21. Carter MJ, Lobo AJ, Travis SP: Guidelines for the management of inflammatory bowel disease in adults. Gut 2004, 53(Suppl 5):V1-V16.
22. Present DH: The knee-elbow position relieves distension [comment]. Gut 1994, 35:1150; Author reply 1.
23. Turner D, Walsh CM, Steinhart AH, Griffiths AM: Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 2007, 5:103-110.
24. Bossa F, Fiorella S, Caruso N, et al.: Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis: a randomized, double-blind trial. Am J Gastroenterol 2007, 102:601-608.
25. Truelove SC, Willoughby CP, Lee EG, Kettlewell MG: Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978, 2:1086-1088.
26. Lichtiger S, Present DH, Kornbluth A, et al.: Cyclosporine in severe ulcerative colitis refractory to steroid therapy [see comment]. N Engl J Med 1994, 330:1841-1845.
27. Poritz LS, Rowe WA, Swenson BR, et al.: Intravenous cyclosporine for the treatment of severe steroid refractory ulcerative colitis: what is the cost? Dis Colon Rectum 2005, 48:1685-1690.
28. Odes HS, Fich A, Reif S, et al.: Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis. Dig Dis Sci 2001, 46:1717-1721.
29. Creed TJ, Probert CS: Review article: steroid resistance in inflammatory bowel disease - mechanisms and therapeutic strategies. Aliment Pharmacol Ther 2007, 25:111-122.
30. Lindgren SC, Flood LM, Kilander AF, et al.: Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 1998, 10:831-835.
31. D'Haens G, Lemmens L, Geboes K, et al.: Intravenous cyclosporine versus intravenous corticosteroids as sing]e therapy for severe attacks of ulcerative colitis. Gastroenterology 2001, 120:1323-1329.
32. Pham CQ, Efros CB, Berardi RR: Cyclosporine for severe ulcerative colitis. Ann Pharmacother 2006, 40:96-101.
33. Kornbluth A, Present DH, Lichtiger S, Hanauer S: Cyclosporin for severe ulcerative colitis: a user's guide. Am J Gastroenterol 1997, 92:1424-1428.
34. Rutgeerts P, Sandborn WJ, Feagan BG, et al.: Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005, 353:2462-2476.
35. Faubion WA, Jr, Loftus EV, Jr, Harmsen WS, et al.: The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001, 121:255-260.
36. Ho GT, Chiam P, Drummond H, et al.: The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 2006, 24:319-330.
37. Tung J, Loftus EV, Jr, Freese DK, et al.: A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2006, 12:1093-1100.
38. D'Amico C, Vitale A, Angriman I, et al.: Early surgery for the treatment of toxic megacolon. Digestion 2005, 72:146-149.
39. Cohen JL, Strong SA, Hyman NH, et al.: Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum 2005, 48:1997-2009.
40. Quigley EM: Colonic dysmotility. In: Clinical Gastroenterology and Hepatology. Edited by Weinstein WM, Hawley CJ, Bosch J. Philadelphia: Elsevier; 2005:473-478.
41. Saunders MD, Kimmey MB: Acute colonic pseudo-obstruction. Clin Perspect Gastroenterol 2000, May/June:156-162.
42. Hutchinson R, Griffiths C: Acute colonic pseudo-obstruction: a pharmacological approach. Ann R Coll Surg Engl 1992, 74:364-367.
43. Pronec RJ, Saunders MD, Kimmey MB: Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999, 341:137-141.
44. Jetmore AB, Timmcke AE, Gathright JB, Jr, et al.: Ogilvie's syndrome: colonic decompression and analysis of predisposing factors. Dis Colon Rectum 1992, 35:135-142.
45. Rex DK: Colonoscopy and acute colonic pseudo-obstruction. Gastrointest Endosc Clin N Am 1997, 7:499-508.
46. Sgouros SN, Vlachogiannakos J, Vassiliadis K, et al.: Effective use of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo-obstruction after resolution of colonic dilation: a prospective, randomized, placebo-controlled trial. Gut 2006, 55:638-640.
47. Duh QY, Way LW: Diagnostic laparoscopy and laparoscopic cecostomy for colonic pseudo-obstruction. Dis Colon Rectum 1993, 36:65-70.
48. Wedel T, Spiegler J, Soellner S, et al.: Enteric nerves and interstitial cells of Cajal are concomitantly altered in patients with slow-transit constipation and megacolon. Gastroenterology 2002, 123:1459-1467.
49. Meier-Ruge WA, Muller-Lobeck H, Stoss F, Bruder E: The pathogenesis of idiopathic megacolon. Eur J Gastroenterol Hepatol 2006, 18:1209-1215.
50. Szarka LA, Pemberton JH: Treatment of megacolon and megarectum. Curr Treat Options Gastroenterol 2006, 9:343-350.